Aker BioMarine wins new Lysoveta contract

Aker BioMarine has secured a new contract for the supply of Lysoveta. The contract value is approximately USD 4 million in 2026, with expected growth in 2027. Gross margin on Lysoveta is significantly higher than for Superba Krill Oil.

"This is exciting news for Lysoveta, a novel ingredient we have worked on commercializing over the past years. We believe the potential for Lysoveta is significant, and we are pleased to see this commercial progress," said Matts Johansen, CEO of Aker BioMarine.

About Lysoveta Lysoveta is a krill-derived ingredient from Aker BioMarine, developed through extensive research. It delivers EPA and DHA in a form that supports transport of omega-3s to the brain. Lysoveta is intended for use in science-based nutrition solutions targeting brain health and healthy aging.

For further information, please contact Christopher Robin Vinter, SVP Finance Mobile: +47 911 60 820 Email: Christopher.vinter@akerbiomarine.com

This information is considered to be inside information pursuant to the EU Market Abuse Regulation article 7 and is subject to the disclosure requirements pursuant to MAR article 17 and Section 5-12 the Norwegian Securities Trading Act. This stock exchange announcement was published by Christopher Vinter, SVP Finance, Aker BioMarine ASA, on May 6, 2026, 13:54 CET

About Aker BioMarine Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.